Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-10-20 Sale | 2021-10-22 9:42 pm | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 36,285 | $31.36 | $1,137,819 | 901,215 (Direct) | View |
| 2021-09-29 Sale | 2021-10-01 4:34 pm | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 29,256 | $27.89 | $815,863 | 937,500 (Direct) | View |
| 2021-09-27 Sale | 2021-09-29 4:05 pm | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 33,244 | $31.9 | $1,060,518 | 966,756 (Direct) | View |
| 2020-01-28 Sale | 2020-01-30 9:06 pm | uniQure N.V. | QURE | SCHAFFER DAVID Director | 806 | $62.27 | $50,190 | 44,915 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-17 Option Award | 2021-05-19 8:34 pm | N/A 2031-05-16 | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director | 22,500 | $0 | 22,500 (Direct) | View |
Ownership | 2020-12-10 7:17 pm | N/A N/A | 4D Molecular Therapeutics Inc. | FDMT | SCHAFFER DAVID Director 10% Owner | 0 | $0 | 2,000,000 (Indirect) | View |
| 2020-02-27 Option Award | 2020-03-02 3:46 pm | N/A 2030-02-27 | uniQure N.V. | QURE | SCHAFFER DAVID Director | 5,683 | $0 | 50,598 (Direct) | View |